The challenged biotech firm, NovaGen Therapeutics, faced severe fiscal difficulties stemming from unsuccessful clinical trials and growing debt. Their internal team lacked the experience to navigate the https://umarqcjo472726.activoblog.com/52297615/biotech-cfo-services-a-case-study-in-monetary-restructuring